Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G.
Ferrero
B
B
Clinica Neurologica, Università di Torino, Italy.
Durelli
L
L
Cavallo
R
R
Dutto
A
A
Aimo
G
G
Pecchio
F
F
Bergamasco
B
B
D001323:Autoantibodies / Q000032:analysis; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007167:Immunotherapy; D009157:Myasthenia Gravis / Q000628:therapy*; D011978:Receptors, Nicotinic / Q000276:immunology
D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D011978:Receptors, Nicotinic